DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Acolbifene
Acolbifene
TE INI (19 ) United States (12 ) Patent Application Publication ( 10) Pub
Cytoplasmic Localization of RXR Determines Outcome in Breast
In Vitro and in Silico Analyses of the Inhibition of Human Aldehyde Oxidase By
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Treatment of Moderate to Severe Dyspareunia with Intravaginal Prasterone Therapy: a Review
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Selective Estrogen Receptor Modulator BC-1 Activates Antioxidant Signaling Pathway in Vitro Via Formation of Reactive Metabolites
Design and Synthesis of Selective Estrogen Receptor Β Agonists and Their Hp Armacology K
Pure Oestrogen Antagonists for the Treatment of Advanced Breast Cancer
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Review Therapeutic Options for Management of Endometrial
WO 2017/059139 Al 6 April 2017 (06.04.2017) P O P C T
Selective Estrogen Receptor Modulator (SERM) Lasofoxifene Forms Reactive Quinones Similar to Estradiol † † Bradley T
Pharmaceutical Appendix to the Tariff Schedule 2
Nexus Between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Product List
Top View
Llllllllllllllllllllllllllllllll^
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Recent Advances on Liquid Chromatographic and Mass Spectrometric Analysis of Selective Estrogen Receptor Modulators (Serms) in Biological Fluids
Cers Report Cover
The Two Tort Dit U N Tali Malta Mauritania
Pharmacology and Toxicology
On the Female Sexual Function in Postmenopausal Women: ERC-230 Open-Label Study
Pharmaabkommen A1 E
Effects of Dehydroepiandrosterone, Premarin and Acolbifene on Histomorphology and Sex Steroid Receptors in the Rat Vagina L
Customs Tariff - Schedule Xxi - 1
Bioactive Compound Library Plus (96-Well)
Regulation of Estrogen Receptor Signaling in Breast And
Estrogen Receptor/ERR
(12) Patent Application Publication (10) Pub. No.: US 2010/0278784 A1 Pojasek Et Al
A Care Pathway from the European Menopause and Andropause Society
The Discovery and Development of Selective Estrogen Receptor Modulators (Serms) for Clinical Practice
Sex Hormones in Lymphedema
Customs Tariff - Schedule Xxi - 1
Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer Carol J
Treatment of Hot Flushes, Vasomotor Symptoms, and Night Sweats with Sex Steroid Precursors in Combination with Selective Estrogen Receptor Modulators
Drug Design: Hiding in Full View à Norman S
Download Product Insert (PDF)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Emerging Hormonal Treatments for Menopausal Symptoms
L:\0900\0900PHARMAPPX .Wpd
Acolbifene Hydrochloride | Medchemexpress
Arzoxifene: a Promising New Selective Estrogen Receptor Modulator for Clinical Chemoprevention of Breast Cancer Commentary Re C
(12) Patent Application Publication (10) Pub. No.: US 2016/0058774 A1 EL-ALFY Et Al
The Synthesis of Novel, Biologically Active Isoflavone Analogues
(12) United States Patent (10) Patent No.: US 7,807,672 B2 Deng Et Al
The Pharmacological Effects of Estrogen Receptor Alpha Y537S and D538G Mutations 3621 Steven J
208470Orig1s000